HairClone is offering a DermalPapillaCell Hair Multiplication procedure in Guatemala, raising questions about its effectiveness and regulatory reasons for the location. Users express skepticism and curiosity about the treatment's success and potential costs.
A Swiss product called Redensyl, which is supposed to target hair follicle stemcells and has recently been marketed in Europe. The post inquires if anyone has had any experience with the product.
AMP-303 and AMP-601 are new hair loss treatments targeting dermalpapillacells, with AMP-303 showing early efficacy in transitioning vellus hairs to terminal hairs after one injection. Further clinical trials are planned, and these treatments are seen as promising due to their biologic approach and less frequent application compared to daily treatments.
Hypoxia may enhance hair growth by stimulating stemcells, but it could also risk fibrosis. Some users humorously discuss extreme methods like choking while using minoxidil, highlighting the need for new treatments.
Epibiotech will offer off-the-shelf allogeneic hair multiplication treatment in South Korea, using dermalpapillacells from donors to grow hair in balding areas. This method is cheaper and less invasive than traditional hair transplants.